These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18519494)
1. Corticosteroid treatment for problematic infantile hemangioma: evidence does not support an increased risk for cerebral palsy. Greene AK Pediatrics; 2008 Jun; 121(6):1251-2. PubMed ID: 18519494 [No Abstract] [Full Text] [Related]
2. [Postnatal steroid treatment--time to reconsider?]. Saugstad OD Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3404. PubMed ID: 10553333 [No Abstract] [Full Text] [Related]
4. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma. Greene AK Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168 [No Abstract] [Full Text] [Related]
5. Hypothalamic-pituitary-adrenal axis suppression in systemic glucocorticoid-treated infantile hemangiomas: putting the risk into context. Sidbury R Arch Dermatol; 2009 Mar; 145(3):319-20. PubMed ID: 19289767 [No Abstract] [Full Text] [Related]
6. [The value isolating distinct factors in cerebral palsy. Application to studies on statistical relations among various etiologic and clinical factors]. Laiter N; Rouquette C; Doyon F; Tardieu G Rev Neuropsychiatr Infant; 1968; 16(1):121-44. PubMed ID: 5683342 [No Abstract] [Full Text] [Related]
7. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis. Onland W; De Jaegere AP; Offringa M; van Kaam AH Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991 [TBL] [Abstract][Full Text] [Related]
8. Cerebral palsy: a regional study. Cussen GH; Barry JE; Moloney AM; Buckley NM; Crowley M; Daly C Ir Med J; 1978 Nov; 71(17):568-72. PubMed ID: 721411 [No Abstract] [Full Text] [Related]
9. [Occurrence of infantile cerebral palsy]. Hejka Z; Janikowski T; Tylicka T; Zmorzyński R Pol Tyg Lek; 1966 May; 21(21):789-90. PubMed ID: 5962797 [No Abstract] [Full Text] [Related]
10. Cerebral palsy. Report on a survey in East Kent. Wright PR; Carey A; Barter RW Ann Phys Med; 1966 Feb; 8(5):175-9. PubMed ID: 5909821 [No Abstract] [Full Text] [Related]
11. Biomarker epidemiology of cerebral palsy. Dammann O; Leviton A Ann Neurol; 2004 Feb; 55(2):158-61. PubMed ID: 14755717 [No Abstract] [Full Text] [Related]
12. [Status and means for improving the care of patients with infantile cerebral palsy]. Mirzoeva II Ortop Travmatol Protez; 1987 Dec; (12):51-5. PubMed ID: 3444641 [No Abstract] [Full Text] [Related]
13. Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication. Wörle H; Maass E; Köhler B; Treuner J Eur J Pediatr; 1999 Apr; 158(4):344. PubMed ID: 10206141 [No Abstract] [Full Text] [Related]
14. [Importance of maternal age and parity in the development of infantile cerebral palsy]. Lubińska-Wykrzykowska L Pediatr Pol; 1976 Feb; 51(2):183-6. PubMed ID: 1256924 [No Abstract] [Full Text] [Related]
16. Spastic diplegia and interferon. Deb G; Jenkner A; Donfrancesco A J Pediatr; 1999 Mar; 134(3):382. PubMed ID: 10064684 [No Abstract] [Full Text] [Related]
17. Trends in the rates of cerebral palsy associated with neonatal intensive care of preterm children. Hack M; Costello DW Clin Obstet Gynecol; 2008 Dec; 51(4):763-74. PubMed ID: 18981801 [TBL] [Abstract][Full Text] [Related]
18. [Possibilities of stereotactic treatment of infantile cerebral palsy- review of personal experiences]. Vladyka V Cesk Neurol Neurochir; 1972; 35(6):281-8. PubMed ID: 4620321 [No Abstract] [Full Text] [Related]